PWP
IDXX icon

Perfromance Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

Perfromance Wealth Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.09M Buy
3,718
+1
+0% +$641 0.06% 58
2025
Q4 		$2.51M Buy
3,717
+126
+4% +$85.8K 0.07% 48
2025
Q3 		$2.29M Sell
3,591
-155
-4% -$94.1K 0.06% 46
2025
Q2 		$2.01M Buy
3,746
+825
+28% +$395K 0.06% 50
2025
Q1 		$1.23M Sell
2,921
-705
-19% -$306K 0.04% 54
2024
Q4 		$1.5M Buy
3,626
+100
+3% +$43.9K 0.05% 55
2024
Q3 		$1.78M Buy
3,526
+110
+3% +$53.4K 0.06% 50
2024
Q2 		$1.66M Hold
3,416
– – 0.06% 45
2024
Q1 		$1.84M Sell
3,416
-35
-1% -$19.1K 0.08% 52
2023
Q4 		$1.92M Sell
3,451
-425
-11% -$200K 0.08% 58
2023
Q3 		$1.69M Hold
3,876
– – 0.08% 65
2023
Q2 		$1.91M Sell
3,876
-255
-6% -$122K 0.09% 65
2023
Q1 		$2.07M Buy
4,131
+1,440
+54% +$689K 0.11% 61
2022
Q4 		$1.1M Sell
2,691
-334
-11% -$130K 0.07% 66
2022
Q3 		$986K Hold
3,025
– – 0.06% 69
2022
Q2 		$1.06M Sell
3,025
-1,200
-28% -$489K 0.06% 67
2022
Q1 		$2.31M Sell
4,225
-4
-0.1% -$2.1K 0.1% 51
2021
Q4 		$2.79M Buy
+4,229
New +$2.65M 0.11% 53

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Perfromance Wealth Partners's IDXX Position: Q1 2026 in Review

Perfromance Wealth Partners increased its Idexx Laboratories (IDXX) stake by 0.03% in Q1 2026, buying an estimated $641 and bringing the position to 3,718 shares worth $2.09M. The position accounts for 0.06% of the portfolio, ranked #58.

Perfromance Wealth Partners first reported a position in IDXX in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.79M in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Perfromance Wealth Partners held 3,718 shares of Idexx Laboratories worth $2.09M as of Q1 2026.
  • Perfromance Wealth Partners bought 1 Idexx Laboratories share in Q1 2026, an estimated $641.
  • Idexx Laboratories made up 0.06% of Perfromance Wealth Partners's portfolio in Q1 2026, its #58 holding.
  • Perfromance Wealth Partners first reported a position in Idexx Laboratories in Q4 2021 and has held it in 18 quarters since.
  • Perfromance Wealth Partners's Idexx Laboratories position peaked at $2.79M in Q4 2021.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Perfromance Wealth Partners's 13F filing for Q1 2026, filed 10 Apr 2026.